Answers are grounded in this paper and cite their sources.
More than two-thirds of patients receiving RT would have a clinical benefit. Low BED regimens appear to be adequate for symptom palliation. Toxicity rates appear acceptable for patients treated with RT alone. The optimal dose fractionation regimen for symptom palliation remains unclear. Prospective studies to determine the effects of palliative gastric RT on HRQL outcomes are warranted.
No takes yet. Share an insight, caveat, or question.
Tey et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: